Moderna, Inc. (MRNA) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Moderna shareholders at a glance

The largest holder of Moderna stock is Fidelity Management & Research Co. LLC, with 51.9 million shares (12.99% of the company), worth about $7.28 billion as of September 25, 2026. The 10 largest holders together own 53.4%.

In Q2 2026, 873 institutional holdings reports listed 346.0 million shares worth $22.70 billion, up 12.3% in shares from Q1 2026.

Insiders reported 83 transactions in the last two years: 14 sales worth $12.30 million and 2 purchases. The newest one on file is from May 15, 2026 (Hoge Stephen, President).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 15, 2026.

MRNA logo

Moderna, Inc.

MRNAUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
873
Options Value
$2.97B
Value (excl. Options)
$22.70B
Shares (excl. Options)
346.00M

Ownership by Type

Geographic Distribution

Largest Moderna shareholders

HolderShares% of companyValue
Fidelity Management & Research Co. LLC51.9 million12.99%$7.3B
BlackRock Advisors LLC25.1 million6.28%$3.5B
Vanguard Capital Management LLC23.2 million5.81%$3.3B
Capital Research & Management Co. (World Investors)22.3 million5.58%$3.1B
Stéphane Bancel5.565 %22.2 million5.57%$3.1B
Baillie Gifford & Co.18.2 million4.56%$2.6B
State Street Corporation15.7 million3.94%$2.2B
Vanguard Portfolio Management LLC15.6 million3.90%$2.2B
Geode Capital Management LLC9.7 million2.43%$1.4B
Eaton Vance Management9.5 million2.39%$1.3B

As of September 25, 2026.

Moderna institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026873346.0 million$22.7B
Q1 2026807308.0 million$15.6B
Q4 2025764305.0 million$9.0B
Q3 2025737277.0 million$7.2B
Q2 2025761303.0 million$8.4B
Q1 2025779282.0 million$8.0B
Q4 2024849277.0 million$11.5B
Q3 2024894265.0 million$17.7B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Moderna insider trades

InsiderDateTitleTransactionValue
Hoge StephenMay 15, 2026PresidentConversion of Exercise of derivative security at price 19.15 per share.$1.0M
Hoge StephenMay 15, 2026PresidentSale at price 48.40 per share.$2.6M
Hussain Shah AbbasMay 1, 2026DirectorSale at price 46.63 per share.$264,952
Hussain Shah AbbasApr 30, 2026Director--–
Tallett Elizabeth EApr 30, 2026Director--–
Rubenstein David MApr 30, 2026Director--–
Nabel Elizabeth GApr 30, 2026Director--–
Horning SandraApr 30, 2026Director--–
Nader Francois E.Apr 30, 2026Director--–
Mock James MApr 2, 2026Chief Financial Officer--–
Klinger Shannon ThymeMar 5, 2026Officer--–
Mock James MMar 5, 2026Chief Financial Officer--–

Newest 12 of 83 insider transactions in the last two years.

Questions and answers

Who owns the most Moderna stock?

Fidelity Management & Research Co. LLC, with 12.99% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.28%) and Vanguard Capital Management LLC (5.81%).

How many institutions own Moderna stock?

873 institutional holdings reports listed Moderna shares in Q2 2026, 346.0 million shares in all worth $22.70 billion.

Are Moderna insiders buying or selling the stock?

In the last two years insiders reported 14 sales and 2 purchases (83 transactions in all); the newest on file is from May 15, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube